April 5-8 in Boston, MA

ASCRS 2024

Interested in Joining Our Happy Hour?

Join us at Lookout Rooftop – a premier waterfront dining destination in Boston, MA. We are thrilled to host this exciting event where we will celebrate you for helping drive innovation in regenerative medicine in the field of Ophthalmology.

Visit our Booth #2787!

Visit booth #2787, at ASCRS 2024 next month to learn how BioTissue Ocular products can help support regenerative healing and provide optimal outcomes to your patients.

BioTissue has been a pioneer in the industry and continues to lead the way in realizing the full potential of regenerative therapies. We are passionate about empowering physicians to help improve patient lives and set the standards that define next-generation care.

Don’t forget to visit our table for Cornea Day on April 5th, where we will highlight how our products can be used for challenging cornea cases and management of severe ocular surface diseases!

Join Us for an Innovator Celebration Happy Hour!

We’re back for our annual ASCRS Happy Hour! Join us at Lookout Rooftop – a premier waterfront dining destination in Boston, MA. We are thrilled to host this exciting event where we will celebrate you for helping drive innovation in regenerative medicine in the field of Ophthalmology.

Ever had a Tricycle Smoothie?

Pedal your way to a vibrant burst of taste with our unique smoothie bike experience – join us for an unforgettable blend of fun, fitness, and fresh ingredients that will leave you buzzing with excitement!

Make sure to stop by Booth #2787 and make your Smoothie!

Featured Papers and Posters

Featured Papers on Birth Tissue:

  • Phototherapeutic Keratectomy with or without Cryopreserved Amniotic Membrane for EBMD and SND Prior to Cataract Surgery by Ankur Parikh, M.D. – Presentation Date: Saturday, April 6th | Session time: 2:20 – 2:25 PM
  • Effect of Cryopreserved Amniotic Membrane on Optimizing the Ocular Surface Prior to Cataract Surgery by Jeff Wongs, MD Session title: Ocular Surface Disease III – Presentation Date: Sunday, April 7th | Session time: 3:30 – 5:00 PM

Additional electronic posters include the following:

  • Cryopreserved Amniotic Membrane for a Scleral Defect Caused By Mitomycin C by Brett Bielory – Poster ID: 99016

Cornea Day:  Session IV on the Ocular Surface that covers severe OSD management and Dry Eye on Friday, April 5th, 2:15 – 3:45 pm

Ocular Healing

BioTissues Family of Amniotic Membrane Products

Early intervention is critical in eye care. Prokera biologic corneal bandages are designed for treating damaged corneas by creating an environment for regenerative healing. Prokera helps expedite and empower the eye’s healing abilities for better patient outcomes.

AmnioGraft, a cryopreserved amniotic membrane graft, supports accelerated post-op recovery and ensures superior patient outcomes when used in ocular surface reconstructive procedures.1,6-7,9

AmnioGuard is an ultra-thick, cryopreserved amniotic membrane graft that suppresses inflammation, promotes healing, and provides durable tensile strength to avoid surgical challenges associated with reconstructive procedures.1-4

Downloadable Resources

  • To access downloadable resources, kindly fill out the form below.
  • By clicking the button below, I agree to receive marketing communications from BioTissue. I am aware that I can unsubscribe at any time.
  • This field is for validation purposes and should be left unchanged.
Sheha H, Tello C, Al-Aswad L, Sayed M, Lee R. Outcomes of the Shunt Tube Exposure Prevention Study (STEPS), a randomized clinical trial. Opthalmol Glaucoma. [Online] August 16, 2019.
Finger PT, Jain P, Mukkamala SK. Super-thick amniotic membrane for ocular surface reconstruction. Am J Opthalmol. 2019;198:45-53.
Slentz, D. and Nelson, C. (2019). Novel Use of Cryopreserved Ultra-thick Human Amniotic Membrane for Management of Anophthalmic Socket Contracture. Ophthalmic Plastic and Reconstructive Surgery, 35(2), pp.193-196.
Johnson, Amy, et al. “Understanding the impact of preservation methods on the integrity and functionality of placental allografts.” Annals of plastic surgery 79.2 (2017): 203-213.
Solomon A, Pires RTF and Tseng SCG. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology. 2001; 108: 449-60.
Cooke M, Tan EK, Mandrycky C, He H, O'Connell J and Tseng SC. Comparison of cryopreserved amniotic membrane and umbilical cord tissue with dehydrated amniotic membrane/chorion tissuJWoundCare. 2014; 23: 465-76.
Tan EK, Cooke M, Mandrycky C, et al. Structural and Biological Comparison of Cryopreserved and Fresh Amniotic Membrane Tissues. Journal of Biomaterials and Tissue Engineering. 2014; 4: 379-88.
Tighe S, Mead O, Lee A and Tseng S. Basic Science Review of Birth Tissue Uses in Ophthalmology. Taiwan Journal of Ophthalmology. 2020;
Kheirkhah A, Casas V, Esquenazi S, et al. New surgical approach for superior conjunctivochalasis. Cornea. 2007;26(6):685-691.
Tseng S, Espana E, Kawakita T, et al. How does amniotic membrane work? The Ocular Surface. 2004; 2(3):177-187.
13. Georgiadis NS, Terzidou CD. Epiphora caused by conjunctivochalasis: treatment with transplantation of preserved human amniotic membrane. Cornea. 2001; 20(6):619-621.